ATE320499T1 - Optimierte proteinsynthese - Google Patents

Optimierte proteinsynthese

Info

Publication number
ATE320499T1
ATE320499T1 AT03812594T AT03812594T ATE320499T1 AT E320499 T1 ATE320499 T1 AT E320499T1 AT 03812594 T AT03812594 T AT 03812594T AT 03812594 T AT03812594 T AT 03812594T AT E320499 T1 ATE320499 T1 AT E320499T1
Authority
AT
Austria
Prior art keywords
protein synthesis
optimized protein
optimized
vitro
proteins
Prior art date
Application number
AT03812594T
Other languages
English (en)
Inventor
Manfred Watzele
Bernd Buchberger
Michael Paulus
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE320499T1 publication Critical patent/ATE320499T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT03812594T 2002-12-09 2003-12-09 Optimierte proteinsynthese ATE320499T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10257479A DE10257479A1 (de) 2002-12-09 2002-12-09 Optimierte Proteinsynthese

Publications (1)

Publication Number Publication Date
ATE320499T1 true ATE320499T1 (de) 2006-04-15

Family

ID=32403731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03812594T ATE320499T1 (de) 2002-12-09 2003-12-09 Optimierte proteinsynthese

Country Status (8)

Country Link
US (1) US20060264612A1 (de)
EP (1) EP1570062B1 (de)
JP (1) JP2006508672A (de)
AT (1) ATE320499T1 (de)
AU (1) AU2003298958A1 (de)
CA (1) CA2507141A1 (de)
DE (2) DE10257479A1 (de)
WO (1) WO2004053053A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1786917A4 (de) * 2004-07-26 2008-05-28 Enzon Pharmaceuticals Inc Optimiertes interferon-beta-gen
EP2447365B1 (de) 2009-06-15 2019-03-27 Toyota Jidosha Kabushiki Kaisha Verwendung von einer lösung für zellfreie proteinsynthese und verfahren zur zellfreien proteinsynthese
GB202207818D0 (en) * 2022-05-27 2022-07-13 Nuclera Nucleics Ltd Linear nucleic acid expression constructs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0328584A1 (de) * 1987-07-13 1989-08-23 Interferon Sciences, Inc. Methode zur verbesserung der translationseffizienz

Also Published As

Publication number Publication date
AU2003298958A8 (en) 2004-06-30
WO2004053053A2 (de) 2004-06-24
AU2003298958A1 (en) 2004-06-30
WO2004053053A3 (de) 2004-09-30
EP1570062B1 (de) 2006-03-15
CA2507141A1 (en) 2004-06-24
EP1570062A2 (de) 2005-09-07
JP2006508672A (ja) 2006-03-16
DE10257479A1 (de) 2004-07-01
DE60304065D1 (de) 2006-05-11
US20060264612A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
PT1644484E (pt) Células autólogas de indução de auto-tolerância de origem monocítica e sua utilização em preparações farmacêuticas
NO20042159L (no) Cellokulturprosess
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DE60207053D1 (de) Rekombinante gelatineartige proteine zur verwendung als plasmaexpander
DE60228847D1 (de)
AU2003209059A1 (en) Human monoclonal antibodies against membrane proteins
GB0208041D0 (en) Method of culturing animal cells
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
AU2003298523A8 (en) Methods for efficient production of mammalian recombinant proteins
WO2004081033A3 (en) Synthesis of proteins by cell-free protein expression
DE60304065D1 (de) Optimierte proteinsynthese
EP1366360A4 (de) Verfahren zum proteinvergleich im grossmassstab
EE05634B1 (et) Geneetiline test kompleksset selgroo v„„rarengut kandvate veiste tuvastamiseks
AU7274801A (en) General means of labeling protein by using wheat embryo cell-free protein synthesis system
WO2002052270A3 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
EP1548443A4 (de) Teststück für protein-assay und prozess zu seiner herstellung
AU2003209735A1 (en) Filament-recruiting fluorescent proteins for the analysis and identification of protein-protein-interactions
DE602004032235D1 (de) Dna-vektoren
ATE392480T1 (de) Verfahren zur vorhersage der expressionseffizienz in zellfreien expressionssystemen
MY142798A (en) Methods for preventing glyconoylation of proteins
NO20053829L (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
ATE433953T1 (de) Peptiddeformylaseinhibitoren
WO2004007671A3 (en) METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN
IT1298437B1 (it) Procedimento per la produzione di proteine/peptidi tossici
BR0303226A (pt) Proteìnas de aderência e penetração de haemophilus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties